DOTA-EB-TATE

CAT: 0804-HY-P10741-01Size: 100 µgDry Ice: NoHazardous: No
CAT#:0804-HY-P10741-01Size:100 µg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DOTA-EB-TATE is composed of SST peptide derivative, DOTA-octreotate conjugated a common to an Evans blue analog (EB) . DOTA-EB-TATE is a peptide drug conjugate (PDC) improves the pharmacokinetics of SSTR2 analogs and reduces PRRT toxicity. DOTA-EB-TATE can also be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) [1][2].
CAS Number
[2151063-66-8]
UNSPSC
12352209
Target
Peptide-Drug Conjugates (PDCs) ; Radionuclide-Drug Conjugates (RDCs) ; Somatostatin Receptor
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related; GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dota-eb-tate.html
Purity
95.42
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
O=[S](O)(C(C(C=C1)=C2C(O)=C1/N=N/C(C=CC(C(C=C3)=CC(C)=C3NC([C@H](CCCCNC(CCN(C(C4)=O)C(C4SCCC(N[C@@H](C(N[C@@H](CSSC[C@H](NC([C@](NC5=O)([H])[C@H](O)C)=O)C(N[C@H](C(O)=O)[C@H](O)C)=O)C(N[C@H](C(N[C@@H](C(N[C@H]5CCCCN)=O)CC6=CNC7=CC=CC=C67)=O)CC8=CC=CC=C8)=O)=O)CC9=CC=CC=C9)=O)=O)=O)NC(CN(CCN(CC%10)CC(O)=O)CCN(CCN%10CC(O)=O)CC(O)=O)=O)=O)=C%11)=C%11C)=CC([S](=O)(O)=O)=C2N)=O
Molecular Formula
C105H133N21O30S5
Molecular Weight
2329.63
References & Citations
[1]Rui Tian, et al. Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy. Theranostics. 2018 Jan 1;8 (3) :735-745. |[2]Vallabhajosula S. Design of Radiolabeled Peptide Radiopharmaceuticals[M]//Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications. Cham: Springer International Publishing, 2023: 577-607.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported

Popular Products